Alembic Pharmaceuticals Ltd.

BSE: 533573 | NSE: APLLTD |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE901L01018 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Alembic Pharma Alembic Pharmaceuticals Ltd. | BSE 784.95 36.05 (4.81%) | NSE 784.75 36.45 (4.87%) | Trade | Add

BSE Live

Apr 17, 16:01

784.95 36.05 (4.81%)

Volume

AVERAGE VOLUME

5-Day

9,935

10-Day

7,995

30-Day

5,584

18,929

Prev. Close

748.90
Open Price

749.85

Bid Price (Qty.)
784.95 (2)
Offer Price (Qty.)
784.95 (1)

NSE Live

Apr 17, 15:58

784.75 36.45 (4.87%)

Volume

AVERAGE VOLUME

5-Day

97,441

10-Day

94,872

30-Day

104,045

238,239

Prev. Close

748.30
Open Price

753.95

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
784.75 (13)

Financials

Print/Copy to Excel : Go

Profit & Loss account of Alembic Pharmaceuticals (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
INCOME
Revenue From Operations [Gross]	5,900.95	5,757.55	5,003.13	4,987.49	4,934.86
Less: Excise/Sevice Tax/Other Levies	0.00	0.00	0.00	0.00	0.00
Revenue From Operations [Net]	5,900.95	5,757.55	5,003.13	4,987.49	4,934.86
Total Operating Revenues	6,032.63	5,874.06	5,149.00	5,035.41	5,051.44
Other Income	47.88	31.32	3.54	51.14	9.73
Total Revenue	6,080.51	5,905.38	5,152.54	5,086.55	5,061.17
EXPENSES
Cost Of Materials Consumed	1,672.17	1,403.01	1,250.08	1,129.11	1,175.71
Purchase Of Stock-In Trade	385.14	449.70	337.21	353.25	279.33
Operating And Direct Expenses	0.00	0.00	31.02	0.00	0.00
Changes In Inventories Of FG,WIP And Stock-In Trade	-268.54	-52.36	72.84	19.87	-157.13
Employee Benefit Expenses	1,466.57	1,335.91	1,094.82	1,062.30	948.27
Finance Costs	76.47	54.47	49.00	17.02	12.77
Depreciation And Amortisation Expenses	277.08	271.14	272.95	284.92	152.60
Other Expenses	1,875.90	1,739.28	1,698.68	1,562.08	1,233.03
Total Expenses	5,484.79	5,201.15	4,806.60	4,428.55	3,644.58
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	595.72	704.23	345.94	658.00	1,416.59
Exceptional Items	12.87	0.00	0.00	0.00	0.00
Profit/Loss Before Tax	608.59	704.23	345.94	658.00	1,416.59
Tax Expenses-Continued Operations
Current Tax	105.98	41.50	0.00	115.70	241.20
Less: MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00
Tax For Earlier Years	-0.51	-3.75	-0.79	-1.25	0.00
Total Tax Expenses	105.47	37.75	-0.79	114.45	241.20
Profit/Loss After Tax And Before ExtraOrdinary Items	503.12	666.48	346.73	543.55	1,175.39
Profit/Loss From Continuing Operations	503.12	666.48	346.73	543.55	1,175.39
Profit/Loss For The Period	503.12	666.48	346.73	543.55	1,175.39
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	25.60	33.91	17.64	27.65	60.67
Diluted EPS (Rs.)	25.60	33.91	17.64	27.65	60.67
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS
Imported Raw Materials	0.00	0.00	0.00	0.00	0.00
Indigenous Raw Materials	0.00	0.00	0.00	0.00	0.00
STORES, SPARES AND LOOSE TOOLS
Imported Stores And Spares	0.00	0.00	0.00	0.00	0.00
Indigenous Stores And Spares	0.00	0.00	0.00	0.00	0.00
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	216.22	157.25	196.56	275.19	0.00
Tax On Dividend	0.00	0.00	0.00	0.00	0.00
Equity Dividend Rate (%)	550.00	550.00	400.00	500.00	700.00